PCI Biotech: US patent for the vaccine technology (fimaVACC) with a new important class of adjuvants NewsKristin EivindvikMarch 26, 2020
PCI Biotech: Update on operational implications of the corona pandemic NewsKristin EivindvikMarch 25, 2020
Invitation to fourth quarter and preliminary 2019 results presentation NewsKristin EivindvikFebruary 19, 2020
PCI Biotech: US patent granted for the vaccine technology (fimaVACC) in combination with cytokines NewsKristin EivindvikJanuary 21, 2020
